Patent Term Application for VYALEV (foscarbidopa and foslevodopa), Patent No. 10,174,061 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0163

Patent Term Application for VYALEV (foscarbidopa and foslevodopa), Patent No. 10,174,061

Documents

Comments

Description

OPEN

Comment Period OpensJan 15, 2025

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Mar 18, 2026	--

CDER

Patent Term Application

Covington & Burling LLP

AbbVie Inc

VYALEV (foscarbidopa and foslevodopa)

Patent No. 10,174,061

OPEN